Inspire Advisors, LLC Viking Therapeutics, Inc. Transaction History
Inspire Advisors, LLC
- $919 Million
- Q3 2025
A detailed history of Inspire Advisors, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Inspire Advisors, LLC holds 22,615 shares of VKTX stock, worth $786,323. This represents 0.06% of its overall portfolio holdings.
Number of Shares
22,615Holding current value
$786,323% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
442Shares Held
67MCall Options Held
7.71MPut Options Held
3.25M-
Vanguard Group Inc Valley Forge, PA10MShares$348 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$210 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$131 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.25MShares$113 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.58MShares$89.6 Million0.0% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.67B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...